Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Weighing BRCA Mutation Testing

September 1st 2010, 9:00am

Article

For those weighing whether to get their BRCA mutation status checked, the potential promise of the PARP inhibitors shouldn’t tip the balance—yet.

New Ovarian Cancer Screening Method Shows Promise

June 20th 2010, 9:00am

Article

Researchers have developed a new screening approach that produces very few false positives in postmenopausal women with an average risk of ovarian cancer.

Longer Use of Avastin Slows Ovarian Cancer

June 15th 2010, 9:00am

Article

Continued use of the targeted drug Avastin (bevacizumab), after initial treatment with the drug and chemotherapy, helped slow progression of advanced ovarian cancer, according to a phase 3 study.

ASCO Updates

June 7th 2010, 9:00am

Article

Updates from the annual meeting of the American Society of Clinical Oncology.

How Should Ovarian Cancer Survivors Be Monitored for Relapse?

September 14th 2009, 9:00am

Article

Treating an ovarian cancer relapse as soon as it can be detected seems like a good idea. But not so fast, a major study has concluded.

Playing the Numbers Game

August 20th 2009, 7:19pm

Article

Ovarian cancer survivors ponder implications of CA-125 study.

ASCO Updates

June 9th 2009, 9:00pm

Article

News from the 2009 annual meeting of the American Society of Clinical Oncology.

CA-125 Monitoring Not Helpful for Ovarian Cancer Survivors

June 7th 2009, 1:03am

Article

Results from an international study challenge current practice of screening for ovarian cancer relapse.

Downsizing Swollen Limbs

December 9th 2008, 11:00am

Article

Controlling lymphedema with the old and the new.

The Pitfalls and Promises of Diagnosing Ovarian Cancer Early

October 24th 2008, 12:10am

Article

Ovarian cancer, also known as “the silent killer,” may soon be detected earlier, giving women improved survival rates, with the recognition of specific early warning signs which including abdominal pain, abdominal bloating, urinary urgency or frequency, pelvic and lower back pressure, loss of appetite or feeling full quickly and abnormal vaginal bleeding.